Showing results (191-200 of 261) with videos related to

Sort By:
Pageof 27
Endocrine|October 14, 2016
Changes in prevalence of obesity and high waist circumference over four years across European regions: the European male ageing study (EMAS)Thang S Han, Elon Correa, Michael E J Lean, et al.
Journal of Andrology|June 27, 2003
Induction of spermatogenesis by recombinant follicle-stimulating hormone (puregon) in hypogonadotropic azoospermic men who failed to respond to human chorionic gonadotropin alonePierre-Marc G Bouloux, Eberhard Nieschlag, Henry G Burger, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 12, 2014
Androgen receptor polymorphism-dependent variation in prostate-specific antigen concentrations of European menMagdalena Bentmar Holgersson, Aleksander Giwercman, , et al.
Frontiers in Endocrinology|November 25, 2022
The Leydig cell biomarker INSL3 as a predictor of age-related morbidity: Findings from the EMAS cohortRichard Ivell, Kee Heng, Katie Severn, et al.
The Journal of Sexual Medicine|March 12, 2008
Assessment of sexual health in aging men in Europe: development and validation of the European Male Ageing Study sexual function questionnaireDaryl B O'Connor, Giovanni Corona, Gianni Forti, et al.
European Journal of Endocrinology|April 5, 2011
Impaired quality of life and sexual function in overweight and obese men: the European Male Ageing StudyThang S Han, Abdelouahid Tajar, Terence W O'Neill, et al.
Age and Ageing|December 19, 2015
Chronic widespread pain is associated with worsening frailty in European menKatie Fredrika Wade, David M Lee, John McBeth, et al.
The Journal of Clinical Endocrinology and Metabolism|June 14, 2017
Nonandrogenic Anabolic Hormones Predict Risk of Frailty: European Male Ageing Study Prospective DataAgnieszka Swiecicka, Mark Lunt, Tomás Ahern, et al.
Pharmacogenetics and Genomics|May 16, 2007
Androgen receptor gene CAG repeat length as a modifier of the association between persistent organohalogen pollutant exposure markers and semen characteristicsAleksander Giwercman, Lars Rylander, Anna Rignell-Hydbom, et al.
Clinical Endocrinology|June 2, 2018
Symptomatic androgen deficiency develops only when both total and free testosterone decline in obese men who may have incident biochemical secondary hypogonadism: Prospective results from the EMASGiulia Rastrelli, Terence W O'Neill, Tomas Ahern, et al.
Pageof 27